Pharmaceutical

Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

New clinical Precision Medicine population data demonstrates up to 84.6 Weeks (19.5 Months) ‘time saved’ by early-start ADAS-Cog13 difference: −5.43...

Elevate Health Technologies Perfects Technology for Medically Integrated Dispensing – Announcing Collaboration with Cervey

HOUSTON, July 30, 2025 /PRNewswire/ -- Elevate Health Technologies, a leading healthcare technology company, is proud to announce a strategic collaboration...

error: Content is protected !!